STRATA Skin Sciences, Inc. (SSKN) Income from Continuing Operations (2010 - 2025)

STRATA Skin Sciences has reported Income from Continuing Operations for 16 years, with the latest figure at 218000.0 in Q4 2025.

• Quarterly Income from Continuing Operations rose 104.75% year-over-year to 218000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 7072000.0 (up 35.63% YoY) and the FY2025 annual result came in at 4888000.0, up 52.41% from the prior year.
• Income from Continuing Operations advanced to 218000.0 in Q4 2025 per SSKN's latest filing, from 1624000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 1082000.0 in Q2 2021 and troughed at 4591000.0 in Q4 2024.
• A 5-year average of 1816300.0 and a median of 1983000.0 in 2022 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2021 and 2023: Income from Continuing Operations surged 164.4% in 2021, then tumbled 2328.75% in 2023.
• Over 5 years, Income from Continuing Operations stood at 849000.0 in 2021, then jumped by 81.15% to 160000.0 in 2022, then sank by 2328.75% to 3886000.0 in 2023, then fell by 18.14% to 4591000.0 in 2024, then jumped by 104.75% to 218000.0 in 2025.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 218000.0, 1624000.0, and 3469000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.